Morgan Stanley analyst Sarita Kapila assumed coverage of UCB (UCBJF) with an Equal Weight rating and EUR 200 price target The firm says the hashers are “priced for perfection.” Published first ...
Morgan Stanley raised the firm’s price target on UCB (UCBJF) to EUR 200 from EUR 105 and keeps an Equal Weight rating on the shares. Published first on TheFly – the ultimate source for real ...
It's easy to miss this feature, but here's where to find it.
Copyright © 2025 MarketWatch, Inc. All rights reserved.
After hours: February 13 at 5:41:33 PM EST ...
At this time, I'd like to welcome everyone to the Biogen fourth-quarter and full-year 2024 earnings call and business update. [Operator instructions] Today's conference is being recorded. Thank you. I ...
But a clear lip liner shakes up the status quo and how we use lip liners. Some may question what the point of a clear lip liner is considering you can’t see it. But it is more functional than ...
Roche already has one Alzheimer’s candidate in its pipeline targeting tau, but has added a second via a deal with Belgian drugmaker UCB worth up to $2 billion. The Swiss pharma group is paying $ ...
After hours: February 10 at 6:40:00 PM EST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback